This retrospective study was conducted to determine the prevalence of HER2 gene amplification by FISH in breast cancer patients with equivocal IHC results (IHC 2+) and to evaluate their clinicopathological characteristics. The gene discussed is ERBB2; the disease is breast carcinoma.